Short description: Diuretics that do not cause potassium loss
Structural formula of the potassium-sparing diuretics. Click to enlarge.
Potassium-sparing diuretics or antikaliuretics[1] refer to drugs that cause diuresis without causing potassium loss in the urine.[2] They are typically used as an adjunct in management of hypertension, cirrhosis, and congestive heart failure.[3] The steroidal aldosterone antagonists can also be used for treatment of primary hyperaldosteronism. Spironolactone, a steroidal aldosterone antagonist, is also used in management of female hirsutism and acne from PCOS or other causes.[4][5]
Normally, sodium is reabsorbed in the collecting tubules of a renal nephron. This occurs via epithelial sodium channels or ENaCs, located on the luminal surface of principal cells that line the collecting tubules. Positively-charged Na+ entering the cells during reabsorption leads to an electronegative luminal environment causing the secretion of potassium (K+) into the lumen/ urine in exchange.[2] Sodium reabsorption also causes water retention.[8][9]
When the kidneys detect low blood pressure, the renin–angiotensin–aldosterone system (RAAS) is activated and eventually, aldosterone is secreted. Aldosterone binds to aldosterone receptors (mineralocorticoid receptors) increasing sodium reabsorption in an effort to increase blood pressure and improve fluid status in the body. When excessive sodium reabsorption occurs, there is an increasing loss of K+ in the urine and can lead to clinically significant decreases, termed hypokalemia. Increased sodium reabsorption also increases water retention.[8][9]
Potassium-sparing diuretics act to prevent sodium reabsorption in the collecting tubule by either binding ENaCs (amiloride, triamterene) or by inhibiting aldosterone receptors (spironolactone, eplerenone). This prevents excessive excretion of K+ in urine and decreased retention of water, preventing hypokalemia.[10]
Because these diuretics are weakly natriuretic, they do not cause clinically significant blood pressure changes and thus, are not used as primary therapy for hypertension.[11] They can be used in combination with other anti-hypertensives or drugs that cause hypokalemia to help maintain a normal range for potassium. For example, they are often used as an adjunct to loop diuretics (usually furosemide) to treat fluid retention in congestive heart failure and ascites in cirrhosis.[11]
Adverse effects
On their own this group of drugs may raise potassium levels beyond the normal range, termed hyperkalemia, which risks potentially fatal arrhythmias. Triamterene, specifically, is a potential nephrotoxin and up to half of the patients on it can have crystalluria or urinary casts.[12][13] Due to its activity as an androgen receptor antagonist and progesterone receptor agonist, spironolactone causes adverse effects, including gynecomastia or decreased libido in males and menstrual abnormalities in females.[14] Spironolactone also causes hyperkalemia[15] and renal insufficiency.[16]
Drug Interactions
Spironolactone interacts with the following medications:[17]
↑"Aldosterone and antialdosterone therapy in congestive heart failure". The American Journal of Cardiology71 (3): A3–A11. January 1993. doi:10.1016/0002-9149(93)90238-8. PMID8422002.
↑"Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society* Clinical Practice Guideline". The Journal of Clinical Endocrinology & Metabolism103 (4): 1233–1257. 1 April 2018. doi:10.1210/jc.2018-00241. PMID29522147.
↑"Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study". Dermatology233 (2–3): 141–144. 2017. doi:10.1159/000471799. PMID28472793.
↑"Safety profile of mineralocorticoid receptor antagonists: Spironolactone and eplerenone". International Journal of Cardiology200: 25–29. December 2015. doi:10.1016/j.ijcard.2015.05.127. PMID26404748.
↑ 11.011.1"Tubular action of diuretics: Distal effects on electrolyte transport and acidification". Kidney International28 (3): 477–489. September 1985. doi:10.1038/ki.1985.154. PMID4068482.